Alphadyne Asset Management »

Cytokinetics shares owned by Alphadyne Asset Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Alphadyne Asset Management from 13F filings

Historical chart of Alphadyne Asset Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Alphadyne Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Alphadyne Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $618k 9.7k 63.54

More positions owned by Alphadyne Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Alibaba Group Hldg Sponsored Ads (BABA)
Meta Platforms Cl A (META)
Wells Fargo & Company (WFC)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. Call Option (JPM)
Morgan Stanley Com New Call Option (MS)

View all positions for Alphadyne Asset Management

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
State Street Corporation
Deep Track Capital
Geode Capital Management
Susquehanna International
Rtw Investments
Goldman Sachs Group
Polar Capital Holdings
Armistice Capital
Integral Health Asset Management
Citadel Advisors

View all funds holding Cytokinetics